Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access

Editor-in-Chief:

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France

Back

Become EABM
Become Reviewer

PREFACE [Hot Topic: Novel Cancer-Targeting Agents/Application Strategies Developed from MMP Science] promotion: free to download

Volume:12   Issue:7
Pp: 687-687
Isao Okazaki
DOI: 10.2174/187152012802650282

Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream

Volume:12   Issue:7
Pp: 688-706
Isao Okazaki and Kazuki Nabeshima
DOI: 10.2174/187152012802650200

Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment

Volume:12   Issue:7
Pp: 707-717
Dimitris Stellas and Evangelia Patsavoudi
DOI: 10.2174/187152012802650246

Modulation of MMPs by Cell Surface Integrin Receptor α5β1

Volume:12   Issue:7
Pp: 726-732
Sekhar Pal, Kirat Kumar Ganguly, Shuvojit Moulik and Amitava Chatterjee
DOI: 10.2174/187152012802650183

MicroRNAs in Cancer: Small Molecules, Big Chances

Volume:12   Issue:7
Pp: 733-743
Mohammed Abba, Giridhar Mudduluru and Heike Allgayer
DOI: 10.2174/187152012802650273

Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science

Volume:12   Issue:7
Pp: 753-763
Isao Okazaki and Yutaka Inagaki
DOI: 10.2174/187152012802650165

MMPs in Ovarian Cancer as Therapeutic Targets

Volume:12   Issue:7
Pp: 764-772
Amer Karam and Oliver Dorigo
DOI: 10.2174/187152012802650174

Regulation of MMPs During Melanoma Progression: From Genetic to Epigenetic

Volume:12   Issue:7
Pp: 773-782
Frank Antonicelli, David Vallerand, Aurélie Trussardi-Regnier, Florent Grange, William Hornebeck and Philippe Bernard
DOI: 10.2174/187152012802650228

A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts

Volume:12   Issue:7
Pp: 791-800
Koshi Kawakami, Miho Hattori, Takatsugu Inoue, Yuriko Maruyama, Junko Ohkanda, Nobuo Kato, Miki Tongu, Takaya Yamada, Miho Akimoto, Keizo Takenaga, Takeshi Sassa, Junji Suzumiy and Yoshio Honma
DOI: 10.2174/187152012802650264

Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition

Volume:12   Issue:7
Pp: 801-806
Jean M. Brunel, Chanaz Salmi-Smail, Audrey Restouin, Thomas Prebet, Norbert Vey and Yves Collette
DOI: 10.2174/187152012802650192

Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents

Volume:12   Issue:7
Pp: 807-817
Andrey A. Toropov, Alla P. Toropova, Emilio Benfenati, Giuseppina Gini, Danuta Leszczynska and Jerzy Leszczynski
DOI: 10.2174/187152012802650255

Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice

Volume:12   Issue:7
Pp: 818-828
Zhisong Cao, John Mendoza, Anthony Kozielski, Xing Liu, Albert DeJesus, Yang Wang, Chang-Guo Zhan, Dana Vardeman and Beppino Giovanella
DOI: 10.2174/187152012802650219

Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma

Volume:12   Issue:7
Pp: 829-834
Yoshihiro Yakushijin, Tomiko Tatsukawa, Takumi Yamaguchi, Takashi Egawa, Noriaki Hidaka, Keiko Ido, Katsuya Suemaru, Masaki Yasukawa and Hiroak Araki
DOI: 10.2174/187152012802650138